DICERNA PHARMACEUTICALS
Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others. The company was founded in 2007 and is headquartered in Lexington, Massachusetts.
DICERNA PHARMACEUTICALS
Industry:
Biotechnology Genetics Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.dicerna.com
Total Employee:
101+
Status:
Closed
Contact:
6176126254
Email Addresses:
[email protected]
Total Funding:
271.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins Sitelinks Search Box
Similar Organizations
A2A Pharmaceuticals
A2A Pharmaceuticals is a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents.
Accera
Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.
Adcentrx Therapeutics
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases
AGTC
AGTC is a biotechnology company conducting human clinical trials of AAV-based gene therapies for the treatment of rare diseases.
Aridis Pharmaceuticals
Aridis is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Biophytis
Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.
Biosystems International
Biosystems International is a biotechnology company engaged in the development of blood-based diagnostics for cancer and chronic diseases.
CardioFocus
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emerillon Therapeutics
Emerillon therapeutics is a biotechnology firm focused on the creation of innovative drug products for the treatment of infectious disease.
EquiTech Therapeutics, LLC
EquiTech Therapeutics, LLC's is a pioneer in the forward development of CRISPR-Cas9 genome editing for equine diseases and therapies.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Genecure
GeneCure is a biotechnology company providing treatments for life-threatening human diseases.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
MagicMed Industries
MagicMed Industries is a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Parabase Genomics
Parabase Genomics is a molecular diagnostics company that focuses on the development of treatments for genetic disorders.
Regeneron
Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Vaccinex
Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.
Verenium
Verenium is an industrial biotechnology company specializing in the development of high performance enzymes.
Vision Genomics
Vision genomics, LLC is a biotechnology company that focuses on research and development of therapeutics for age-related eye diseases.
ZaBeCor Pharmaceuticals
ZaBeCor Pharmaceuticals, LLC, a clinical stage biotechnology company, focuses on the development of siRNA, antisense, and other molecular
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Eli Lilly
Eli Lilly investment in Post-IPO Equity - Dicerna Pharmaceuticals
Cowen Group
Cowen Group investment in Post-IPO Equity - Dicerna Pharmaceuticals
Skyline Ventures
Skyline Ventures investment in Post-IPO Debt - Dicerna Pharmaceuticals
Domain Associates
Domain Associates investment in Post-IPO Debt - Dicerna Pharmaceuticals
RA Capital Management
RA Capital Management investment in Post-IPO Debt - Dicerna Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Debt - Dicerna Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Debt - Dicerna Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Debt - Dicerna Pharmaceuticals
Abingworth
Abingworth investment in Series C - Dicerna Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series C - Dicerna Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-22 | Dicerna Announces New Executive Leadership Appointments |
| 2020-05-07 | Dicerna Announces Appointment of Douglas Pagà n as Chief Financial Officer |
Official Site Inspections
http://www.dicerna.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.94 K
- Host name: 199.47.130.30
- IP address: 199.47.130.30
- Location: Dallas United States
- Latitude: 32.7767
- Longitude: -96.805
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75202
More informations about "Dicerna Pharmaceuticals"
Dicerna Pharmaceuticals - Crunchbase Company …
Organization. Dicerna Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Dicerna Pharmaceuticals is a biotechnology company with a focus on the …See details»
Dicerna Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
Nov 1, 2024 Explore Dicerna Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 27 clinical trials, 87 news, and 63 literature, Disease …See details»
Dicerna Pharmaceuticals, Inc. - Organisation Profile - Lix
Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute …See details»
Dicerna Pharmaceuticals Inc - AnnualReports.com
Dicerna Pharmaceuticals Inc reports have an aggregate usefulness score of 4.8 based on 166 reviews. Dicerna Pharmaceuticals Inc. Most Recent Annual …See details»
Dicerna Pharmaceuticals - Contacts, Employees, Board Members, …
Dicerna Pharmaceuticals has 4 board members and advisors, including Stephen J. Hoffman. Stephen J. Hoffman Board Member Oct 2007 Cynthia Smith Board Member 2018See details»
Dicerna - Overview, News & Similar companies | ZoomInfo.com
Dec 24, 2021 Who is Dicerna. Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for rare, chronic liver, cardiov …See details»
Dicerna Pharmaceuticals - Craft
Dicerna Pharmaceuticals is a clinical-stage biopharmaceutical company that focuses on the discovery and development of treatments for rare inherited diseases. It offers GalXC, a liver …See details»
Dicerna Pharmaceuticals, INC Company Profile | Boulder, CO ...
Find company research, competitor information, contact details & financial data for Dicerna Pharmaceuticals, INC of Boulder, CO. Get the latest business insights from Dun & Bradstreet.See details»
Dicerna Pharmaceuticals - Funding, Financials, Valuation & Investors
Dicerna Pharmaceuticals is registered under the ticker NASDAQ:DRNA . Their stock opened with $15.00 in its Jan 31, 2014 IPO. Stock Symbol NASDAQ:DRNA ; Valuation at IPO $188M; …See details»
Dicerna Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The …
View Dicerna Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified …See details»
Dicerna Pharmaceuticals - Overview, News & Competitors
Dicerna Pharmaceuticals. Manufacturing · Massachusetts, United States · 41 Employees. Dicerna Pharmaceuticals Inc is a company that operates in the Pharmaceuticals industry. It employs …See details»
Dicerna Company Profile | Management and Employees List
Find contact information for Dicerna. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Dicerna's email format.See details»
Dicerna Pharmaceuticals - PitchBook
Dicerna Pharmaceuticals General Information Description. Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments …See details»
Dicerna Pharmaceuticals Inc: Overview - GlobalData
Dicerna Pharmaceuticals Inc, a subsidiary of Novo Nordisk AS, is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and …See details»
News Details - Novo Nordisk
Nov 18, 2021 Novo Nordisk to acquire Dicerna Pharmaceuticals including the RNAi research technology platform. Bagsværd, Denmark, 18 November 2021 – Novo Nordisk today …See details»
Dicerna Announces New Executive Leadership Appointments
Sep 22, 2021 Dicerna today announced new executive leadership appointments. Rob Ciappenelli Appointed Chief Strategy Officer and Marc Abrams, Ph.D., Promoted to Senior …See details»
Dicerna Pharmaceuticals - Scientist.com
Dicerna Pharmaceuticals 480 Arsenal Street Watertown, MA, 02472 United States: Get started If your organization has a Scientist.com marketplace, you can log in here to order products and …See details»
News Details - Novo Nordisk
Novo Nordisk has been advised by the depositary for the tender offer that a total of approximately 64,946,526 shares of Dicerna’s common stock were validly tendered and not validly withdrawn …See details»
Dicerna Pharmaceuticals (USA) Funding: $433.5M - Medical Startups
Nov 26, 2024 Dicerna Pharmaceuticals develops therapeutic agents in various disease areas based on dicer substrate technology platform. The company offers RNA interference (RNAi) …See details»
Working at Dicerna Pharmaceuticals - Zippia
Mar 14, 2024 Zippia gives an in-depth look into the details of Dicerna Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about …See details»